The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.


REGISTRATION IS OPEN till 19 April (paid registrations) & 22 April (free registrations).

Register now to save your place at the CDDF Multi-Stakeholder Workshop in April 2021!

For more information about the registration process & registration deadline, scroll down the page.



CDDF Industry partner (*) Free
Non-commercial participant (academia/ foundation / charity) Free
A representative from regulatory authority (EMA, FDA, national agency and HTA body) (**) Free
Nurse & student   Free
Patient advocate (***) Free
Pharmaceutical company representative (non-partner of CDDF) EUR 500 (+21% VAT)
Miscellaneous – nonmedical, consultancy, freelancer, etc. EUR 500 (+21% VAT)


(*) The list of CDDF Industry Partners is available here 

(**) The representative from regulatory authority’ rate applies to an individual who is employed by a regulatory authority such as EMA, FDA, a national agency, and HTA body. 

(***) The Patient advocate’s rate applies to an individual who is a member of a Patient Advocacy Organisation. 


















Free registration

Registration deadline: Thursday 22 April 2021

Paid registration (see Registration fee)
  • Registration deadline: Monday 19 April 2021
  • Payment deadline: Thursday 22 April 2021 (registration fee should be paid by the given deadline to complete paid registration)

Please note that only written cancellations addressed to will be accepted with the following rules:

  • Before 12 April 2021: 50% refund
  •  After 12 April 2021 (including): no refund
CDDF Data Protection Policy

Please read the CDDF’s ‘Data Protection Policy.’

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70